ATXI
Price:
$2.83
Market Cap:
$4.05M
Avenue Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes products primarily for use in the acute/intensive care hospital setting. Its product candidate is intravenous Tramadol, a synthetic dual-acting opioid, which is in Phase III clinical trials for the treatment of post-operative acute pain. The company was incorporated in 2015 and is based in New York, New York.[Read more]
Industry
Biotechnology
IPO Date
2017-06-27
Stock Exchange
NASDAQ
Ticker
ATXI
According to Avenue Therapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is 0.08. This represents a change of -99.90% compared to the average of 81.20 of the last 4 quarters.
The mean historical PE Ratio of Avenue Therapeutics, Inc. over the last ten years is -573.34. The current 0.08 PE Ratio has changed -101.40% with respect to the historical average. Over the past ten years (40 quarters), ATXI's PE Ratio was at its highest in in the September 2023 quarter at 204.51. The PE Ratio was at its lowest in in the September 2020 quarter at -3263.12.
Average
-573.34
Median
-310.83
Minimum
-1721.96
Maximum
92.83
Discovering the peaks and valleys of Avenue Therapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 226.72%
Maximum Annual PE Ratio = 92.83
Minimum Annual Increase = -129.86%
Minimum Annual PE Ratio = -1721.96
Year | PE Ratio | Change |
---|---|---|
2023 | -0.16 | -100.18% |
2022 | 92.83 | -129.86% |
2021 | -310.83 | -78.53% |
2020 | -1447.44 | 226.72% |
2019 | -443.02 | 127.34% |
2018 | -194.87 | 32.61% |
2017 | -146.96 | -91.47% |
2016 | -1721.96 | 74.35% |
The current PE Ratio of Avenue Therapeutics, Inc. (ATXI) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-72.72
5-year avg
-421.73
10-year avg
-573.34
Avenue Therapeutics, Inc.’s PE Ratio is greater than Hoth Therapeutics, Inc. (-0.98), greater than Revelation Biosciences, Inc. (-0.09), greater than NeuroBo Pharmaceuticals, Inc. (-0.73), greater than Virax Biolabs Group Limited (-1.34), greater than Panbela Therapeutics, Inc. (-0.06), greater than Palisade Bio, Inc. (-0.31), greater than Quoin Pharmaceuticals, Ltd. (-0.47), greater than ContraFect Corporation (-0.11), greater than Allarity Therapeutics, Inc. (-0.19), greater than CNS Pharmaceuticals, Inc. (-0.00), greater than Windtree Therapeutics, Inc. (-0.14), less than Kiromic BioPharma, Inc. (0), greater than Biodexa Pharmaceuticals Plc (-0.14), greater than null (-0.05),
Company | PE Ratio | Market cap |
---|---|---|
-0.98 | $7.32M | |
-0.09 | $1.43M | |
-0.73 | $29.70M | |
-1.34 | $15.24M | |
-0.06 | $1.75M | |
-0.31 | $4.25M | |
-0.47 | $3.06M | |
-0.11 | $1.72M | |
-0.19 | $7.01M | |
-0.00 | $4.60M | |
-0.14 | $1.66M | |
0 | $3.14M | |
-0.14 | $105.64K | |
-0.05 | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Avenue Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Avenue Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Avenue Therapeutics, Inc.'s PE Ratio?
How is the PE Ratio calculated for Avenue Therapeutics, Inc. (ATXI)?
What is the highest PE Ratio for Avenue Therapeutics, Inc. (ATXI)?
What is the 3-year average PE Ratio for Avenue Therapeutics, Inc. (ATXI)?
What is the 5-year average PE Ratio for Avenue Therapeutics, Inc. (ATXI)?
How does the current PE Ratio for Avenue Therapeutics, Inc. (ATXI) compare to its historical average?